每年專案
個人檔案
學歷
- 1996 美國約翰霍普金斯大學公共衛生（健康政策與管理學）博士
- 1987 台灣大學國際貿易學系學士
經歷
- 2007 臺北醫學大學醫務管理學系教授
- 1997 臺北醫學大學醫務管理學系副教授
研究興趣
- 健康經濟學
- 經濟評估
指紋
查看啟用 Chao-Hsiun Tang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
Chemotherapeutic regimens and chemotherapy-free intervals influence the survival of patients with recurrent advanced epithelial ovarian carcinoma: A retrospective population-based study
Huang, H. Y., Chiang, C. J., Chen, Y. Y., You, S. L., Hsu, H. C., Tang, C. H. & Cheng, W. F., 六月 2 2021, 於: International journal of environmental research and public health. 18, 12, 6629.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan
Li, K. J., Chang, C. L., Hsin, C. Y. & Tang, C. H., 七月 21 2021, 於: Frontiers in Pharmacology. 12, 628548.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
The impact of atopic dermatitis on health-related quality of life in Taiwan
Hsieh, B. J., Shen, D., Hsu, C. J., Chan, T. C., Cho, Y. T., Tang, C. H. & Chu, C. Y., 2021, (接受/付印) 於: Journal of the Formosan Medical Association.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan
Liu, Y., Tang, C-H., Qiu, H., Siggins, S. & Hou, H-A., 一月 13 2021, 於: Scientific Reports. 11, 1, p. 1112研究成果: 雜誌貢獻 › 文章 › 同行評審
2 引文 斯高帕斯（Scopus） -
Treatment patterns and survival in patients with small cell lung cancer in Taiwan
Chiang, C. L., Hsieh, W. T., Tang, C. H., Sheu, M. L. & Chen, Y. M., 八月 1 2021, 於: Journal of the Chinese Medical Association. 84, 8, p. 772-777 6 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
Protein-energy wasting significantly increases healthcare utilization and costs among patients with chronic kidney disease: a propensity-score matched cohort study
Chao, C. (Contributor), Tang, C. (Contributor), Cheng, R. W. (Contributor), Wang, M. Y. (Contributor) & Hung, K. (Contributor), Unknown Publisher, 九月 2 2017
DOI: 10.6084/m9.figshare.5198317.v1, https://tandf.figshare.com/articles/figure/Protein-energy_wasting_significantly_increases_healthcare_utilization_and_costs_among_patients_with_chronic_kidney_disease_a_propensity-score_matched_cohort_study/5198317/1
資料集: Dataset
-
Factors affecting discontinuation of adalimumab and etanercept therapy in anti-TNF-naïve patients with ankylosing spondylitis: Nationwide population-based cohort study
Chen, H. (Contributor), Chen, Y. (Contributor), Lai, K. (Contributor), Lin, C. (Contributor), Tang, C. (Contributor) & Chen, D. (Contributor), Unknown Publisher, 九月 8 2015
DOI: 10.6084/m9.figshare.1601856.v1, https://tandf.figshare.com/articles/journal_contribution/Factors_affecting_discontinuation_of_adalimumab_and_etanercept_therapy_in_anti_TNF_na_239_ve_patients_with_ankylosing_spondylitis_Nationwide_population_based_cohort_study/1601856/1
資料集: Dataset
-
A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study
Chiu, Y. (Contributor), Tang, C. (Contributor), Hung, S. (Contributor), Yang, Y. (Contributor), Fang, C. (Contributor) & Lin, H. (Contributor), Unknown Publisher, 五月 4 2017
DOI: 10.6084/m9.figshare.4047471.v1, https://tandf.figshare.com/articles/journal_contribution/A_real-world_risk_analysis_of_biological_treatment_adalimumab_and_etanercept_in_a_country_with_a_high_prevalence_of_tuberculosis_and_chronic_liver_disease_a_nationwide_population-based_study/4047471/1
資料集: Dataset